Menu

ACE 2023 - Issues 20 A & B

  • Claim Credits by 4/30/2024
  • Online Activity
Credits Available: CME, AANA

Now available for preorder! Issue 20A will be available in April 2023. Issue 20B will be available in October 2023.

Expiration dates to claim credit:
20A: 4/30/2024
20B: 10/31/2024

Test your knowledge of anesthesia fundamentals!

Developed by...  Read More +




Item Details

The American Society of Anesthesiologists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Society of Anesthesiologists designates this enduring material for a maximum of 60 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit for Canadian MOC Participants: Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

For information on other accreditations, contact ASA Member Services at (847) 825-5586.

The 2023 issues are currently available for preorder. Issue 20A will be available in April 2023. Issue 20B will be available in October 2023.

After successfully completing this activity, the learner will be able to:

  • Assess the current state of his or her knowledge of fundamental and subspecialty anesthesia topics and identify knowledge gaps
  • Develop a strategy to address identified gaps using resources provided as references within the program
  • Utilize enhanced knowledge in clinical practice
This activity is intended for anesthesiologists, anesthesia residents, and members of the anesthesia care team.

Joel O. Johnson, MD, PhD
Co-Editor-in-Chief
Madison, Wisconsin

Stacy L. Jones, MD, MHA, FASA
Co-Editor-in-Chief
Little Rock, Arkansas

Anuj K. Aggarwal, MD
Stanford, California

Shamsuddin Akhtar, MD 
New Haven, Connecticut\

Richard P. Dutton, MD, MBA, FASA
Dallas, Texas

Bhargavi Gali, MD
Rochester, Minnesota

Russell K. McAllister, MD, FASA
Temple, Texas

Shobana Rajan, MD, FASA
Houston, Texas

Sara Robertson, MD, FASA
Madison, Mississippi

Ahmed Shalabi, MBBCh, MSc, FCAI
Los Angeles, California

Johannes W. Steyn, MD
Nicholasville, Kentucky

Kofi B. Vandyck, MD
Oklahoma City, Oklahoma 

Additional Contributor: Kathryn Rouine-Rapp, MD, San Francisco, California

ASA Staff: Ginger Clark, Managing Editor

Resolution of Conflicts of Interest: ASA remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of ASA to eliminate all situations of potential conflict of interest, but rather to enable those who are working with ASA to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the educational activity course director/chair to ensure that such situations are properly evaluated and, if necessary, resolved. ASA educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all ASA activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.

Ineligible companies are those not eligible to be accredited by the Accreditation Council for Continuing Medical Education because the primary business of these companies is producing, marketing, selling, reselling, or distributing health care products used by or on patients. The faculty and staff below have reported the following financial relationships with ineligible companies:

Anuj K. Aggarwal, MD
AbbVie: Stock (self)
Gilead Sciences: Stock (self)
GlaxoSmithKline: Stock (self)
Pfizer: Stock (self)

Ginger Clark
Merck: Stock (self)
Organon & Co: Stock (self)

Jennifer M. Hah, MD
Nalu Medical: Independent contractor—consultant (self)
SPR Therapeutics, Inc: Independent contractor—consultant (self)

Kofi B. Vandyck, MD
Abiomed: Stock (self)
Medtronic: Stock (self)
General Electric: Stock (self)
Johnson & Johnson Health Care Systems Inc: Stock (self)
Edwards Lifesciences: Stock (self)
Quantra QStat Study: Independent contractor—other (self)

All disclosed financial relationships have been mitigated. All other faculty, planners, and staff have reported no financial relationships with ineligible companies.

Internet connection. Web browser: Google Chrome, Microsoft Edge, Mozilla Firefox, or Safari, updated within the last 3 years.
ACE 2023 - Issues 20 A & B
ACE 2023 Products
Select ACE 2023 Products
select